Evidence map›Paper›PMID 39011363›Full record

ArticleFrontiers in neurology2024

Development of the Huntington Support App (HD-eHelp study): a human-centered and co-design approach.

Pearl J C van Lonkhuizen, Anne-Wil Heemskerk, Eline Meijer, Erik van Duijn, Susanne T de Bot, Jiri Klempir, G Bernhard Landwehrmeyer, Alzbeta Mühlbäck, Jennifer Hoblyn, Ferdinando Squitieri and 3 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pearl J C van LonkhuizenDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Anne-Wil HeemskerkDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Eline MeijerDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Erik van DuijnDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Susanne T de BotDepartment of Neurology, Leiden University Medical Center, Leiden, Netherlands.
Jiri KlempirDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.
G Bernhard LandwehrmeyerDepartment of Neurology, University Hospital Ulm, Ulm, Germany.
Alzbeta MühlbäckDepartment of Neurology, University Hospital Ulm, Ulm, Germany.
Jennifer HoblynSt. John of God Hospital, Trinity College Dublin, Dublin, Ireland.
Ferdinando SquitieriHuntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza Research Hospital, San Giovanni Rotondo, Italy.
Niels H ChavannesDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Niko J H VegtDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
HEALTHE-RND consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: eHealth seems promising in addressing challenges in the provision of care for Huntington's disease (HD) across Europe. By harnessing information and communication technologies, eHealth can partially relocate care from specialized centers to the patients' home, thereby increasing the availability and accessibility of specialty care services beyond regional borders. Previous research on eHealth (development) in HD is however limited, especially when it comes to including eHealth services specifically designed together with HD gene expansion carriers (HDGECs) and their partners to fit their needs and expectations. Methods: This article describes the qualitative human-centered design process and first evaluations of the Huntington Support App prototype: a web-app aimed to support the quality of life (QoL) of HDGECs and their partners in Europe. Prospective end-users, i.e., HDGECs, their partners, and healthcare providers (HCPs), from different countries were involved throughout the development process. Through interviews, we captured people's experiences with the disease, quality of life (QoL), and eHealth. We translated their stories into design directions that were further co-designed and subsequently evaluated with the user groups. Results: The resulting prototype centralizes clear and reliable information on the disease, HD-related news and events, as well as direct contact possibilities with HCPs via an online walk-in hour or by scheduling an appointment. The app's prototype was positively received and rated as (very) appealing, pleasant, easy to use and helpful by both HDGECs and partners. Discussion: By involving end-users in every step, we developed a healthcare app that meets relevant needs of individuals affected by HD and therefore may lead to high adoption and retention rates. As a result, the app provides low-threshold access to reliable information and specialized care for HD in Europe. A description of the Huntington Support App as well as implications for further development of the app's prototype are provided.

Indexed as

eHealthhuman-centeredHuntington’s diseaseneurodegenerative diseasesquality of lifetelemedicinetele-neurology

Identifiers

PMID39011363
PMCPMC11246862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.